# Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial

Study · id `cardio:ct-nct03811119` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03811119](<https://clinicaltrials.gov/study/NCT03811119>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03811119

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT03811119. Randomized; no masking; primary purpose treatment. Start 2018-10-30 (actual); primary completion 2020-02-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT03811119, source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)
- Started: 2018-10-30 (actual) (ClinicalTrials.gov record NCT03811119, source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)
- Primary completion: 2020-02-01 (actual) (ClinicalTrials.gov record NCT03811119, source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)
- Completion: 2020-04-30 (actual) (ClinicalTrials.gov record NCT03811119, source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT03811119, source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03811119-2021-03-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial
- Acronym: MASH-TAVI
- Condition: Aortic Valve Stenosis
- Intervention (Device): MANTA vascular closure device
- Intervention (Device): Suture based vascular closure device
- Lead sponsor: Erasmus Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Erasmus Medical Center (`cardio:org-erasmus-medical-center`)

## Provenance

Content hash: 1202d29617cd4df9bed58d60d5545247e955ec69c616b5a4a9d3da9885840905
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
